Figure 4.
Stratified analysis of the association of LHR, MHR, NHR, and PHR with MASLD and significant liver fibrosis according to sex. (a) MASLD; (b) significant liver fibrosis. LHR, lipoprotein-cholesterol ratio; MASLD, metabolic dysfunction-associated steatotic liver disease; MHR, monocyte-HDL-C ratio; NHR, neutrophil-HDL-C ratio; PHR, platelet-HDL-C ratio.
